CIITA versus IFN-γ induced MHC class II expression in head and neck cancer cells

Archives of Dermatological Research

Volumn 301, Issue 2, 2009, Pages 189-193

  Meissner, Markus ^a   Whiteside, Theresa L ^b   Kaufmann, Roland ^a   Seliger, Barbara ^c  

^a GOETHE UNIVERSITY   (Germany)

^b UNIVERSITY OF PITTSBURGH CANCER INSTITUTE   (United States)

^c MARTIN LUTHER UNIVERSITY HALLE WITTENBERG   (Germany)

Author keywords

Antigen processing; Head and neck cancer; IFN ; MHC class II

Indexed keywords

CATHEPSIN S; CLASS II TRANSACTIVATOR PROTEIN; GAMMA INTERFERON; HLA DM ANTIGEN; HLA DR ANTIGEN; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 1; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2; MESSENGER RNA; TRANSACTIVATOR PROTEIN; UNCLASSIFIED DRUG;

ANTIGEN EXPRESSION; ARTICLE; CANCER CELL; CELL SURFACE; CONTROLLED STUDY; HEAD AND NECK CANCER; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

CARCINOMA, SQUAMOUS CELL; CATHEPSINS; CELL LINE, TUMOR; GENES, MHC CLASS II; HEAD AND NECK NEOPLASMS; HLA-D ANTIGENS; HLA-DR ANTIGENS; HUMANS; INTERFERON-GAMMA; NUCLEAR PROTEINS; RNA, MESSENGER; TRANS-ACTIVATORS; TRANSFECTION;

EID: 59449091869     PISSN: 03403696     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00403-008-0922-6     Document Type: Article

References (18)

1. SN Andersen TO Rognum E Lund GI Meling S Hauge 1993 Strong HLA-DR expression in large bowel carcinomas is associated with good prognosis Br J Cancer 68 80 85
2. H Bosshart RF Jarrett 1998 Deficient major histocompatibility complex class II antigen presentation in a subset of Hodgkin's disease tumor cells Blood 92 2252 2259
3. N Coleman MA Stanley 1994 Analysis of HLA-DR expression on keratinocytes in cervical neoplasia Int J Cancer 56 314 319
4. FV Cromme PF van Bommel JM Walboomers MP Gallee PL Stern P Kenemans TL Helmerhorst MJ Stukart CJ Meijer 1994 Differences in MHC and TAP-1 expression in cervical cancer lymph node metastases as compared with the primary tumours Br J Cancer 69 1176 1181
5. G Dranoff E Jaffee A Lazenby 1993 Vaccination with irradiated tumor cells engineered to secrete murine granulocyte-macrophage colony-stimulating factor stimulates potent, specific, and long-lasting anti-tumor immunity Proc Natl Acad Sci USA 90 3539 3543
6. S Flynn B Stockinger 2003 Tumor and CD4+ T-cell interactions: tumor escape as result of reciprocal inactivation Blood 101 4472 4478
7. K Hung R Hayashi A Lafond-Walker C Lowenstein D Pardoll H Levitsky 1998 The central role of CD4(+) T cells in the antitumor immune response J Exp Med 188 2357 2368
8. Meissner M, Whitside TL, van Kuik-Romein P, Valesky EM, van den Elsen PJ, Kaufmann R, Seliger B (2008) Loss of interferon-inducibility of the MHC class II antigen processing pathway in head and neck cancer: evidence for post-transcriptional as well as epigenetic regulation. Br J Dermatol 158(5):930-940
9. M Meissner TE Reichert M Kunkel W Gooding TL Whiteside S Ferrone B Seliger 2005 Defects in the human leukocyte antigen class I antigen processing machinery in head and neck squamous cell carcinoma: association with clinical outcome Clin Cancer Res 11 7 2552 2560
10. Y Morimoto M Toyota A Satoh M Murai H Mita H Suzuki Y Takamura H Ikeda T Ishida N Sato T Tokino K Imai 2004 Inactivation of class II transactivator by DNA methylation and histone deacetylation associated with absence of HLA-DR induction by interferon-gamma in haematopoietic tumour cells Br J Cancer 90 844 852
11. L Mortara P Castellani R Meazza G Tosi A De Lerma Barbaro FA Procopio A Comes L Zardi S Ferrini RS Accolla 2006 CIITA-induced MHC class II expression in mammary adenocarcinoma leads to a Th1 polarization of the tumor microenvironment, tumor rejection, and specific antitumor memory Clin Cancer Res 12 3435 3443
12. DM Pardoll SL Topalian 1998 The role of CD4+ T cell responses in antitumor immunity Curr Opin Immunol 10 588 594
13. A Satoh M Toyota H Ikeda Y Morimoto K Akino H Mita H Suzuki Y Sasaki T Kanaseki Y Takamura H Soejima T Urano 2004 Epigenetic inactivation of class II transactivator (CIITA) is associated with the absence of interferon-gamma- induced HLA-DR expression in colorectal and gastric cancer cells Oncogene 23 8876 8886
14. B Shi A Vinyals P Alia C Broceno F Chen M Adrover C Gelpi JE Price A Fabra 2006 Differential expression of MHC class II molecules in highly metastatic breast cancer cells is mediated by the regulation of the CIITA transcription. Implication of CIITA in tumor and metastasis development Int J Biochem Cell Biol 38 544 562
15. B Sikorska M Danilewicz M Wagrowska-Danilewicz 1999 HLA-DR expression is a significant prognostic factor in laryngeal cancer. A morphometric study Apmis 107 383 388
16. O Stüve S Youssef AJ Slavin CL King JC Patarroyo DL Hirschberg WJ Brickey JM Soos JF Piskurich HA Chapman SS Zamvil 2002 The role of the MHC class II transactivator in class II expression and antigen presentation by astrocytes and in susceptibility to central nervous system autoimmune disease J Immunol 169 12 6720 6732
17. N van der Stoep P Biesta E Quinten PJ van den Elsen 2002 Lack of IFN-gamma-mediated induction of the class II transactivator (CIITA) through promoter methylation is predominantly found in developmental tumor cell lines Int J Cancer 97 501 507
18. H Wiendl A Lautwein M Mitsdörffer S Krause S Erfurth W Wienhold M Morgalla E Weber HS Overkleeft H Lochmüller A Melms E Tolosa 2003 Antigen processing and presentation in human muscle: cathepsin S is critical for MHC class II expression and upregulated in inflammatory myopathies J Neuroimmunol 138 1-2 132 143